FOR RELEASE: APRIL 11, 2017, 6:05 A.M. EDT

Contact: Darryl Mitteldorf, LCSW

Malecare Says African American Men Are Inadequately Addressed by Recent USPSTF Draft Recommendations on Screening for Prostate Cancer

New York, NY April 11, 2017—Malecare finds that the April 11, 2017 U.S. Preventive Services Task Force (USPSTF) draft recommendation statement on Screening for Prostate Cancer will cause harm to African American men.

Malecare is pleased to see the USPSTF upgrade its recommendation for prostate cancer screening to a “C” for men ages 55 to 69, with a positive suggestion that each man should form his own choice regarding screening. However, the current crisis regarding prostate cancer and African American men suggests that a more proactive approach is a more appropriate method.

African American men are at an increased risk of developing and dying from prostate cancer. African American men are 1.6 times more likely to develop prostate cancer than whites and 2.6 times more likely than Asian Americans. African American men experience longer delays between diagnosis and treatment. African American men under the age of 60 are more likely to be diagnosed with advanced stage prostate cancer. Malecare feels that the USPSTF prostate cancer screening guidelines should include special reference that African American men should be offered the PSA test within this context. (Reference: )


About Malecare 
Founded in 1997, Malecare is America’s leading men’s cancer survivor support and advocacy national nonprofit organization. We strive to be first in understanding and implementing evidence based research and new technology in service to our cancer survivor population. We are known for our men’s health programs for underserved populations, like African-American and LGBT cancer survivors. All of our services are provided without cost to the patient and their family.